Ciencias Químicas
Facultat
![Foto de Ciencias Químicas](/img/uploaded/F9DD5DC76A96F8B726E155338CC9E85E.jpg)
![Foto de University of Cagliari](/img/noimage_org.png)
University of Cagliari
Cagliari, ItaliaPublicacions en col·laboració amb investigadors/es de University of Cagliari (28)
2024
2023
-
Evolutionary adaptation from hydrolytic to oxygenolytic catalysis at the α/β-hydrolase fold
Chemical Science, Vol. 14, Núm. 38, pp. 10547-10560
-
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 11, pp. 2851-2874
2022
-
EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 1, pp. 17-38
2021
-
COVID-19 pandemic and allergen immunotherapy—an EAACI survey
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 11, pp. 3504-3516
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
-
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate-to-severe atopic dermatitis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 988-1009
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 6, pp. 1629-1639
-
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 45-58
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 8, pp. 2337-2353
-
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 59-70
-
Multiscale Workflow for Modeling Ligand Complexes of Zinc Metalloproteins
Journal of Chemical Information and Modeling, Vol. 61, Núm. 11, pp. 5658-5672
2020
-
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie
Allergologie, Vol. 43, Núm. 7, pp. 255-271
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 11, pp. 2764-2774
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network
Allergy: European Journal of Allergy and Clinical Immunology
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
2019
-
Assessing the impact of design factors on the performance of two miniature microbial fuel cells
Electrochimica Acta, Vol. 297, pp. 297-306